Background COVID‐19 illness is highly variable, ranging from infection with no symptoms
through to pneumonia and life‐threatening consequences. Symptoms such as fever, cough …

Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …

Chemosensory scientists have been skeptical that reports of COVID-19 taste loss are
genuine, in part because before COVID-19 taste loss was rare and often confused with smell …

The prevalence of chemosensory dysfunction in patients with COVID-19 varies greatly
between populations. It is unclear whether such differences are due to factors at the level of …

Abstract Background Among Coronavirus Disease 2019 (COVID-19) manifestations,
Olfactory (OD) and Gustatory (GD) Dysfunctions (OGD) have drawn considerable attention …

Abstract In March 2020, the Global Consortium of Chemosensory Research (GCCR) was
founded by chemosensory researchers to address emerging reports of unusual smell and …

Emerging viral infections are a ceaseless challenge and remain a global public health
concern. The world has not yet come back to normal from the devastating effects of the …

Transient loss of smell is a common symptom of influenza and other upper respiratory
infections. Loss of taste is possible but rare with these illnesses, and patient reports of 'taste …

Olfactory dysfunction (OD) and gustatory dysfunction (GD) has been reported as one of the
presenting symptoms amongst COVID-19 patients. However the literature available is …

Objective Olfactory and gustatory dysfunction (OGD) are important early clinical symptoms of
COVID-19. We aim to calculate the pooled prevalence of these symptoms and discuss the …